From January 1, 2024 to January 11, 2024, the company has repurchased 1,049,800 shares, representing 0.22% for CNY 60 million. With this, the company has completed the repurchase of 1,696,800 shares, representing 0.36% for CNY 99.99 million under the buyback announced on December 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.85 CNY | -0.15% | +6.52% | -34.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.71% | 2.64B | |
-16.90% | 8.36B | |
+50.91% | 3.84B | |
-9.28% | 2.48B | |
-9.89% | 2.33B | |
-3.77% | 1.98B | |
-17.29% | 1.6B | |
-36.54% | 1.27B | |
+5.98% | 1.11B | |
-13.91% | 920M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.